| Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. | |
| | |
MedLine Citation:
|
PMID: 19686413 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND AIM: To profile changes of coagulation, anticoagulation and fibrolytic factors associated with liver function failure and portal vein thrombosis (PVT) formation in chronic liver cirrhosis patients. METHODS: A total of 116 cirrhotic patients admitted to our hospital from June 2006 to October 2008 were included in our study. All patients were classified into two groups: PVT group (31 patients), composed of patients with PVT and a control group (85 patients), including patients without PVT. Platelet, prothrombin time (PT), activated partial prothrombin time (APTT) and fibrinogen were measured. Also, plasma samples from the patients were analyzed for the levels of antithrombin III (AT-III), protein C (PC), protein S (PS), D-dimer, tissue-type plasminogen activator as well as plasminogen activator inhibitor-1. Statistical analyses were carried out to evaluate the correlation of specific variations with the disease status. RESULTS: In general, the higher Child-Pugh scores, indicating the aggravation of hepatic impairment of the patients, correlated well with the prolonged PT/APTT and increased D-dimer, as well as decreased platelet, fibrinogen, PC and AT-III levels in the serum. Furthermore, we found that the PC, PS and D-dimer levels in PVT patients were 2.32 +/- 0.72 mg/L, 17.14 +/- 3.62 mg/L and 0.99 +/- 0.36 mg/L, respectively, both representing a significant difference compared with those in the control group without PVT. Logistic regression model shows that the odds ratio value of one unit of increase of PC and D-dimer were 0.48 and 15.57. CONCLUSIONS: Cirrhotic patients displayed dysfunctions in the coagulation, anti-coagulation and fibrolytic systems. The development of PVT in these patients may be independently associated with the decrease of PC, PS and D-dimer. Furthermore, decreasing PC and increasing D-dimer may be risk factors inducing PVT in cirrhotic patients. |
| | |
Authors:
|
Donglei Zhang; Jianyu Hao; Ning Yang |
Related Documents
:
|
3080043 - Associated von willebrand disease as a possible cause of lack of thrombosis in an at ii... 8039353 - Prognostic role of screening tests of haemostasis and underlying diseases in acute diss... 18484253 - The foot: still the most important reason for walking incapacity in rheumatoid arthriti... |
Publication Detail:
|
Type: Journal Article Date: 2009-08-03 |
Journal Detail:
|
Title: Journal of gastroenterology and hepatology Volume: 25 ISSN: 1440-1746 ISO Abbreviation: J. Gastroenterol. Hepatol. Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-02-08 Completed Date: 2010-05-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8607909 Medline TA: J Gastroenterol Hepatol Country: Australia |
Other Details:
|
Languages: eng Pagination: 116-21 Citation Subset: IM |
Affiliation:
|
Beijing Chaoyang Hospital Affiliate of Capital Medical University, Department of Gastroenterology, Beijing, China. zdlzdl52973@sina.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Antithrombin III / analysis Biological Markers / blood Blood Coagulation* Case-Control Studies Chronic Disease Female Fibrin Fibrinogen Degradation Products / analysis* Humans Liver Cirrhosis / blood*, complications Logistic Models Male Middle Aged Odds Ratio Partial Thromboplastin Time Platelet Count Portal Vein* Protein C / analysis* Protein S / analysis Prothrombin Time Risk Assessment Risk Factors Venous Thrombosis / blood, etiology* |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Fibrin Fibrinogen Degradation Products; 0/Protein C; 0/Protein S; 0/fibrin fragment D; 9000-94-6/Antithrombin III |
| Comments/Corrections | |
Comment In:
|
J Gastroenterol Hepatol. 2010 Jan;25(1):1-2
[PMID:
20136967
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Preoperative colonoscopy for patients with gastric adenocarcinoma.
Next Document: Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients wit...